Deal Watch: Bristol Teams Up With Insitro, Sensyne In AI-Directed Collaborations
Executive Summary
Pharma pays $50m up front to tap insitro’s in vitro modeling technology, partners with Sensyne Health in blood disorders. Lilly’s COVID-19 partner AbCellera teams with Kodiak in ophthalmology R&D.